Mesoblast leads the pack with 8.7% share price gain
MELBOURNE: Stem cell treatments maker Mesoblast finished today’s session up 8.7 per cent ... read more
Intelicare flags major traction from recent marketing drive
PERTH: Health tech company InteliCare Holdings (ASX:ICR) has provided a market update today ... read more
Permira-owned I-MED’s $1.01b loan hints at M&A
SYDNEY: Private equity owned I-MED Radiology Network is restocking its acquisition warchest as ... read more
Alzheimer’s drug decision unsurprisingly splits experts
WASHINGTON D.C. : US regulators have approved the first ever medication for Alzheimer’s ... read more
